Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:2525305rdf:typepubmed:Citationlld:pubmed
pubmed-article:2525305lifeskim:mentionsumls-concept:C1551338lld:lifeskim
pubmed-article:2525305lifeskim:mentionsumls-concept:C0263382lld:lifeskim
pubmed-article:2525305lifeskim:mentionsumls-concept:C0050559lld:lifeskim
pubmed-article:2525305lifeskim:mentionsumls-concept:C0392747lld:lifeskim
pubmed-article:2525305lifeskim:mentionsumls-concept:C0302350lld:lifeskim
pubmed-article:2525305lifeskim:mentionsumls-concept:C1554963lld:lifeskim
pubmed-article:2525305pubmed:issue4lld:pubmed
pubmed-article:2525305pubmed:dateCreated1989-7-18lld:pubmed
pubmed-article:2525305pubmed:abstractTextWe report on a 50-year-old woman having suffered from atypically located Kyrle's disease for 2 years. Especially the palmoplantar areas were affected by keratotic erythematous papules showing the typical histologic picture of Kyrle's disease. Treatment with acitretin (initial dose 30 mg/day) resulted in almost complete remission after 6 months. A concomitant lichen nitidus remained unchanged.lld:pubmed
pubmed-article:2525305pubmed:languagegerlld:pubmed
pubmed-article:2525305pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:2525305pubmed:citationSubsetIMlld:pubmed
pubmed-article:2525305pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:2525305pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:2525305pubmed:statusMEDLINElld:pubmed
pubmed-article:2525305pubmed:monthAprlld:pubmed
pubmed-article:2525305pubmed:issn0301-0481lld:pubmed
pubmed-article:2525305pubmed:authorpubmed-author:MarschW CWClld:pubmed
pubmed-article:2525305pubmed:authorpubmed-author:WolterMMlld:pubmed
pubmed-article:2525305pubmed:authorpubmed-author:BaumerF EFElld:pubmed
pubmed-article:2525305pubmed:issnTypePrintlld:pubmed
pubmed-article:2525305pubmed:day15lld:pubmed
pubmed-article:2525305pubmed:volume64lld:pubmed
pubmed-article:2525305pubmed:ownerNLMlld:pubmed
pubmed-article:2525305pubmed:authorsCompleteYlld:pubmed
pubmed-article:2525305pubmed:pagination286, 289-91lld:pubmed
pubmed-article:2525305pubmed:dateRevised2008-11-21lld:pubmed
pubmed-article:2525305pubmed:meshHeadingpubmed-meshheading:2525305-...lld:pubmed
pubmed-article:2525305pubmed:meshHeadingpubmed-meshheading:2525305-...lld:pubmed
pubmed-article:2525305pubmed:meshHeadingpubmed-meshheading:2525305-...lld:pubmed
pubmed-article:2525305pubmed:meshHeadingpubmed-meshheading:2525305-...lld:pubmed
pubmed-article:2525305pubmed:meshHeadingpubmed-meshheading:2525305-...lld:pubmed
pubmed-article:2525305pubmed:meshHeadingpubmed-meshheading:2525305-...lld:pubmed
pubmed-article:2525305pubmed:meshHeadingpubmed-meshheading:2525305-...lld:pubmed
pubmed-article:2525305pubmed:meshHeadingpubmed-meshheading:2525305-...lld:pubmed
pubmed-article:2525305pubmed:year1989lld:pubmed
pubmed-article:2525305pubmed:articleTitle[The Kyrle disease entity and its therapeutic modification by acitretin (etretin)].lld:pubmed
pubmed-article:2525305pubmed:affiliationZentrum der Dermatologie und Venerologie, Abt. I, J.W. Goethe-Universität, Frankfurt am Main.lld:pubmed
pubmed-article:2525305pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:2525305pubmed:publicationTypeEnglish Abstractlld:pubmed
pubmed-article:2525305pubmed:publicationTypeCase Reportslld:pubmed